When Using DOPPS Slides

1. When Using DOPPS Slides

2. DOPPS Slide Use Guidelines

3. C-Reactive Protein (CRP) and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

4. Introduction

5. DOPPS Background (1)

6. DOPPS Background (2)

7. Methods

8. Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (1)

9. Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (2)

10. Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (3)

11. Table 2. Baseline Characteristics for Patients by High vs Low Facility Percentage CRP Measurement, all DOPPS Countries Except US and Canada (1)

12. Table 2. Baseline Demographics for Patients by High vs Low Facility Percentage CRP Measurement, all Countries Except US and Canada (2)

13. Table 2. Baseline Demographics for Patients by High vs Low Facility Percentage CRP Measurement, all Countries Except US and Canada (3)

14. Table 3. Mortality Hazards Ratio (HR) by Facility Percent of Patients with CRP Measurement

20. Conclusions

21. Acknowledgements